The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Psoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Self-citationEtanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Krueger, G. G., Koo, J. Y. M., Lebwohl, M., Menter, A., Stern, R. S., & Rolstad, T. (2001) · PubMed · Cited by 969
Self-citationIrvine, E. J., Feagan, B., Rochon, J., Archambault, A., Fedorak, R. N., Groll, A., Kinnear, D., Saibil, F., & McDonald, J. W. D. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90585-1 · Cited by 712
Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes
Ellis, C. N., & Krueger, G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450403 · Cited by 582
Self-citationRelman, A. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811033191810 · Cited by 580
Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)
Best, W. R., Becktel, J. M., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90384-6 · Cited by 562
A Randomized Trial of Etanercept as Monotherapy for Psoriasis
Gottlieb, A. B. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.12.1627 · Cited by 470
The outcomes movement—Will it get us where we want to go?
Epstein, A. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230410 · Cited by 371
Krueger, G. G., Papp, K. A., Stough, D. B., Loven, K. H., Gulliver, W. P., & Ellis, C. N. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.127247 · Cited by 338
Self-citationAbrams, J. R., Kelley, S. L., Hayes, E., Kikuchi, T., Brown, M. J., Kang, S., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Linsley, P. S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.681 · Cited by 318
Self-citationFORTUNE, D. G., MAIN, C. J., O'SULLIVAN, T. M., & GRIFFITHS, C. E. M. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.19472062.x · Cited by 304
Ashcroft, Po, L. W., Williams, & Griffiths (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02963.x · Cited by 287
Methotrexate for psoriasis. A new therapeutic schedule
Weinstein, G. D. (1971) · Archives of Dermatology · doi:10.1001/archderm.103.1.33 · Cited by 268
The Self-Administered Psoriasis Area and Severity Index Is Valid and Reliable
Feldman, S. R., Fleischer, A. B., Reboussin, D. M., Rapp, S. R., Lyn Exum, M., Clark, A. R., & Nurre, L. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12329912 · Cited by 267
Self-citationQuantifying the harmful effect of psoriasis on health-related quality of life
Weiss, S. C., Kimball, A. B., Liewehr, D. J., Blauvelt, A., Turner, M. L., & Emanuel, E. J. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122755 · Cited by 265
Krueger, J. G., Wolfe, J. T., Nabeya, R. T., Vallat, V. P., Gilleaudeau, P., Heftler, N. S., Austin, L. M., & Gottlieb, A. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.2057 · Cited by 248
Self-citationGottlieb, A. B., Krueger, J. G., Wittkowski, K., Dedrick, R., Walicke, P. A., & Garovoy, M. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.5.591 · Cited by 230
Self-citationThe impact of psoriasis on quality of life
de Arruda, L. H. F., & de Moraes, A. P. F. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.00034.x · Cited by 222
Felson, D. T., Anderson, J. J., Lange, M. L. M., Wells, G., & LaValley, M. P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9%3c1564::aid-art6%3e3.0.co;2-m · Cited by 197
Tugwell, P., Wells, G., Strand, V., Maetzel, A., Bombardier, C., Crawford, B., Dorrier, C., & Thompson, A. K. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<506::aid-anr5>3.0.co;2-u · Cited by 173
Which outcome measures should be used in rheumatoid arthritis clinical trials?.
Buchbinder, R., Bombardier, C., Yeung, M., & Tugwell, P. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381108 · Cited by 170
Physical and psychologic measures are necessary to assess overall psoriasis severity
Kirby, B., Richards, H. L., Woo, P., Hindle, E., Main, C. J., & Griffiths, C. E. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114592 · Cited by 162
An Evaluation of Utility Measurement in Crohnʼs Disease
Gregor, J. C., McDonald, J. W., Klar, N. S., Wall, R., Atkinson, K., Lamba, B., & Feagan, B. G. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030405 · Cited by 158
The Salford Psoriasis Index: an holistic measure of psoriasis severity
Kirby, B., Fortune, D. G., Bhushan, M., Chalmers, R. J. G., & Griffiths, C. E. M. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03418.x · Cited by 152
Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial
Bhushan, M., Bleiker, T. O., Ballsdon, A. E., Allen, M. H., Sopwith, M., Robinson, M. K., Clarke, C., Weller, R., GRAHAM-BROWN, R. A. C., Keefe, M., et al. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04743.x · Cited by 140
Strand, V., Tugwell, P., Bombardier, C., Maetzel, A., Crawford, B., Dorrier, C., Thompson, A. K., Wells, G. A., & on behalf of the LEFLUNOMIDE RHEUMATOID ARTHRITIS INVESTIGATORS GROUP (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9<1870::aid-anr11>3.0.co;2-d · Cited by 136
The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort
McKenna, K. E., & Stern, R. S. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)80214-9 · Cited by 119
Coping and quality of life in patients with psoriasis
Wahl, A., Hanestad, B., Wiklund, I., & Moum, T. (1999) · Quality of Life Research · doi:10.1023/a:1008944108101 · Cited by 101
Wahl, A. K., Burckhardt, C. S., Wiklund, I. E., & Hanestad, B. R. (1998) · Scandinavian Journal of Caring Sciences · doi:10.1111/j.1471-6712.1998.tb00500.x · Cited by 97
Quality of life measures in psoriasis: a critical appraisal of their quality
Ashcroft, D. M., Po, A. L. W., Williams, H. C., & Griffiths, C. E. M. (1998) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.1998.00181.x · Cited by 62
Wahl, A., Moum, T., Hanestad, B., & Wiklund, I. (1999) · Quality of Life Research · doi:10.1023/a:1008935921866 · Cited by 44
Wahl, A. K., Burckhardt, C. S., Wiklund, I. E., et al. (1998) · Scandinavian Journal of Caring Sciences · doi:10.1080/02839319850162823 · Cited by 32
Etanercept in the treatment of psoriatic arthritis and psoriasis
Takada, K. (2000) · Arthritis Research & Therapy · doi:10.1186/ar-2000-66866 · Cited by 28
Cited by
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Self-citationA Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Self-citationPsoriasis assessment tools in clinical trials
Feldman, S. R., & Krueger, G. G. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.031237 · Cited by 557
Self-citationCurrent severe psoriasis and the Rule of Tens
Finlay, A. Y. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06502.x · Cited by 394
Metadata
- Authors
- Carlin, C. S., Feldman, S. R., Krueger, J. G., Menter, A., & Krueger, G. G.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 50
- Issue
- 6
- Pages
- 859-866
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2065523538
- Cited by
- 278
- References
- 36
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.